AnnCatherine Downing is a drug development leader and clinical trialist currently serving as the Senior Director and Chief Operating Officer of Portfolio and Project Management at Eli Lilly and Company, where they drive innovative asset strategies from preclinical phases through phase II in immunology and rare diseases. Previously, AnnCatherine held various roles at Eli Lilly, including Clinical Research Advisor and Principal Clinical Research Scientist, focusing on neurodegenerative diseases and schizophrenia. They began their career at Target as a Relief Pharmacist before earning a Doctor of Pharmacy from Butler University in 2002.
This person is not in any teams
This person is not in any offices